<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883790/" ref="ordinalpos=3818&amp;ncbi_uid=2681184&amp;link_uid=PMC2883790" image-link="/pmc/articles/PMC2883790/figure/F2/" class="imagepopup">Fig. 2.  From: mTOR <span class="highlight" style="background-color:">SIGNALING</span> IN CANCER CELL MOTILITY AND TUMOR METASTASIS. </a></div><br /><div class="p4l_captionBody">Schematic of IGF-I activation of a signaling pathway to mTOR. mTOR protein exists in two distinct complexes, mTORC1 and mTORC2. mTORC1, which receives input from several upstream pathways, including PI3K/Akt, TSC1/TSC2, and AMPK, phosphorylates downstream effectors S6K and 4EBP1 and regulates ribosome biogenesis, cell growth, autophagy, cell motility and metabolism. mTORC2 phosphorylates Akt at Ser473 and regulates the actin cytoskeleton and cell motility. Arrows represent activation, whereas bars represent inhibition.</div></div>